Paper40575656
Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.
Yan Y and 6 others. Mater Today Bio, 2025. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin. Papers, record 40575656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40575656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References211
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22927762 | Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22927762 | PubMed |
| 2 | 39941855 | Curcumin and Its Derivatives in Hepatology: Therapeutic Potential and Advances in Nanoparticle Formulations. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941855 | PubMed |
| 3 | 39591076 | Improvement in Curcumin's Stability and Release by Formulation in Flexible Nano-Liposomes. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39591076 | PubMed |
| 4 | 22609787 | Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. | Molecules | 2012 | https://conductscience.org/library/papers/22609787 | PubMed |
| 5 | 25749519 | NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10. | Oncotarget | 2015 | https://conductscience.org/library/papers/25749519 | PubMed |
| 6 | 29751694 | Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes. | Molecules | 2018 | https://conductscience.org/library/papers/29751694 | PubMed |
| 7 | 36144994 | The Potential of Curcumin-Capped Nanoparticle Synthesis in Cancer Therapy: A Green Synthesis Approach. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/36144994 | PubMed |
| 8 | 17341611 | Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. | Ann N Y Acad Sci | 2006 | https://conductscience.org/library/papers/17341611 | PubMed |
| 9 | 33405725 | Bioinspired Polymerization of Quercetin to Produce a Curcumin-Loaded Nanomedicine with Potent Cytotoxicity and Cancer-Targeting Potential in Vivo. | ACS Biomater Sci Eng | 2019 | https://conductscience.org/library/papers/33405725 | PubMed |
| 10 | 33496383 | Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line. | Environ Toxicol | 2021 | https://conductscience.org/library/papers/33496383 | PubMed |
| 11 | 12473670 | Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12473670 | PubMed |
| 12 | 36152892 | Ferritin nanocage based delivery vehicles: From single-, co- to compartmentalized- encapsulation of bioactive or nutraceutical compounds. | Biotechnol Adv | 2022 | https://conductscience.org/library/papers/36152892 | PubMed |
| 13 | 39943855 | Nanoencapsulation enhanced the performance of β-carotene for ameliorating inflammation in patient-derived organoids. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/39943855 | PubMed |
| 14 | 37492509 | Curcumin-loaded mesoporous silica nanoparticles for drug delivery: synthesis, biological assays and therapeutic potential - a review. | RSC Adv | 2023 | https://conductscience.org/library/papers/37492509 | PubMed |
| 15 | 29025645 | Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA/ZnO nanoparticles. | Mater Sci Eng C Mater Biol Appl | 2018 | https://conductscience.org/library/papers/29025645 | PubMed |
| 16 | 37504415 | Dual pH- and Thermo-Sensitive Poly(N-isopropylacrylamide-co-allylamine) Nanogels for Curcumin Delivery: Swelling-Deswelling Behavior and Phase Transition Mechanism. | Gels | 2023 | https://conductscience.org/library/papers/37504415 | PubMed |
| 17 | 30669284 | Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30669284 | PubMed |
| 18 | 14500688 | Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. | J Immunol | 2003 | https://conductscience.org/library/papers/14500688 | PubMed |
| 19 | 7559628 | Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7559628 | PubMed |
| 20 | 17555831 | Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/17555831 | PubMed |
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974146 | Curcumin pharmacology and pharmacokinetics: current challenges and future perspectives in nanoemulsion delivery. | Beilstein J Nanotechnol | 2026 | https://conductscience.org/library/papers/42974146 | PubMed |
| 42930824 | Electrospun Nanofiber Therapeutics for Localized Post-Surgical Breast Cancer Treatment. | J Funct Biomater | 2026 | https://conductscience.org/library/papers/42930824 | PubMed |
| 42893963 | CDK4/6 Inhibitors and Curcumin Synergistically Suppress HER2- Breast Cancer via Lethal ROS and Inhibition of Metastasis. | Cancer Sci | 2026 | https://conductscience.org/library/papers/42893963 | PubMed |
| 42830956 | Macrophage-Based Nanoplatforms for Tumor-Targeted Drug Delivery and Cancer Immunomodulation: Extracellular Vesicles, Membrane-Coated Nanoparticles, and Live Cells. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42830956 | PubMed |
| 42699515 | Plant polyphenols as context-dependent modulators of cellular signalling networks. | Front Nutr | 2026 | https://conductscience.org/library/papers/42699515 | PubMed |
| 42683198 | Natural Medicines Modulating Tumor Perineural Invasion: Regulatory Mechanisms and Therapeutic Potential. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42683198 | PubMed |
| 42645768 | Curcumin-loaded PEGylated Magnetic Iron Oxide Nanoparticles: a Biogenic Platform for Targeted and Controlled Drug Release. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42645768 | PubMed |
| 42539521 | Curcumin Attenuates Breast Cancer Cell-induced Inflammasome Activation via the NOD-like receptor protein 3/Caspase-1/Interleukin-1β Axis. | J Cancer Prev | 2026 | https://conductscience.org/library/papers/42539521 | PubMed |
| 42464296 | Advanced herbal self-assembled nanoplatforms: targeted, stimuli-responsive, and precision therapeutics for human diseases. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42464296 | PubMed |
| 42376460 | The emerging role of oncolytic virotherapy in genitourinary malignancies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42376460 | PubMed |
| 42370350 | Curcumin as theranostics: imaging-guided therapeutics in oncology and neurodegenerative diseases. | Front Nutr | 2026 | https://conductscience.org/library/papers/42370350 | PubMed |
| 42351108 | A magnetic resonance imaging-guided drug delivery system for premetastatic niche theranostics and colorectal cancer liver metastasis intervention. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42351108 | PubMed |
| 42311420 | Intranasal Delivery of Curcumin-Loaded Pure Drug Self-Assembled Lipid-Based Nanoparticles for Targeted Therapy of Depression. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42311420 | PubMed |
| 42243927 | Histone modifications across cancers: mechanisms, therapy and clinical translation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42243927 | PubMed |
| 42176148 | Nature meets immunity: curcumin's role in modulating neutrophil extracellular traps. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42176148 | PubMed |
| 42137470 | A QbD-optimized magnetic MOF-chitosan nanocarrier for targeted curcumin delivery and synergistic antimicrobial activity. | RSC Adv | 2026 | https://conductscience.org/library/papers/42137470 | PubMed |
| 42088575 | The oxidative stress-inflammation self-perpetuating cycle in multiple sclerosis: from mechanisms to emerging antioxidant strategies. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42088575 | PubMed |
| 42075010 | Turmeric: A Comprehensive Review of Its Botany, Traditional Uses, Phytochemistry, and Mechanisms as a Functional Food. | Nutrients | 2026 | https://conductscience.org/library/papers/42075010 | PubMed |
| 42038028 | Targeting MUC16 to Reverse Anoikis Resistance: A Promising Strategy for Metastatic Lung Adenocarcinoma Therapy. | J Cancer | 2026 | https://conductscience.org/library/papers/42038028 | PubMed |
| 41823875 | Curcumin Enhances Gemcitabine Sensitivity in Breast Cancer Cells Through ROS-Associated Mitochondrial Apoptosis and Transcriptional Reprogramming. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41823875 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40575656
GET https://conductscience.org/api/papers/v1/40575656/references?page=2